Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab

@article{Fujinaga2012CyclosporineVM,
  title={Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab},
  author={Shuichiro Fujinaga and Tomonosuke Someya and Tsuneki Watanabe and Akira Ito and Yoshiyuki Ohtomo and Toshiaki Shimizu and Kazunari Kaneko},
  journal={European Journal of Pediatrics},
  year={2012},
  volume={172},
  pages={513-518}
}
The efficacy of rituximab (RTX) as the sole therapy for preventing relapses of nephrotic syndrome (NS) is transient in most patients; therefore, the optimal therapy required for maintaining a successful response to a biological agent remains a challenge. We conducted a prospective study to compare the efficacy of cyclosporine (CsA) with that of… CONTINUE READING